Blue Cross Blue Shield of Massachusetts is trying a new way of paying hospitals and doctors. Instead of paying for every hospital visit and surgery, the insurance giant is offering a flat, annual fee per patient. Stacey Vanek-Smith reports.
A company called 23andMe is now offering a direct-to-consumer genetic testing service. For $999 it will give you a detailed analysis of your DNA. But might that be the very definition of too much information? Ashley Milne-Tyte reports.
Pennsylania's governor has reversed an effort to ban milk-container labels that tell consumers the milk comes from cows not treated with a growth hormone. Consumer groups are hailing his decision. Sarah Gardner reports.
The drug Vytorin has been a multibillion-dollar blockbuster -- although it hasn't exactly been the cholesterol buster it was supposed to be. Commentator and physician Dr. Stefan Kertesz says it's a cautionary tale about the process of approving new pharmaceuticals.
Intensive care units are the biggest money pits in most hospitals. Some medical facilities are turning to electronic ICUs, which save money through big economies of scale. But what are the real costs? Marianne Russ reports.